302-440-1481 Menu

Rithem Life Sciences Announces Formation of Strategic Advisory Board

04/26/2021

Wilmington DE, April 26, 2021 – Rithem Life Sciences, a Wilmington, Delaware-based medical device company and developer of safe and efficacious life-saving portable products, has announced the formation of its Strategic Advisory Board.

The Strategic Advisory Board will collaborate with Rithem’s leadership team as the company continues advancing the development of its portable, hands-only CPR aid – ResQR and the automated external defibrillator – JoltzAED. The ResQR is ergonomically designed with advanced features such as a placement indicator as well as metronome and LED light guidance to ensure proper positioning of the hands during chest compressions. This allows for the equal spreading of force across the wider surface area of the sternum to reduce the risk of fractures. It is also equipped with a compression pacing system and built-in modesty and personal protection equipment to avoid unnecessarily exposing the recipient’s chest while also reducing the risk of potential exposure to and transmission of viruses such as COVID-19.

The Strategic Advisory Board is comprised of the following members:

Major General (Ret.) Larry Harrington is a Hall of Fame athlete, highly decorated military leader, accomplished businessman and entrepreneur. He is also an honored public servant, recognized civic leader, and proud family man. Major General Harrington’s career includes assignments in some of the most demanding, complex, and strategically relevant leadership positions. A few highlights of his distinguished career include tactically significant combat assignments, humanitarian relief operations, nation building, and military facilities managements. As an experienced and successful businessman, Major General Harrington has held management and leadership positions in several Fortune 500 companies. As an entrepreneur, he owns several successful small businesses performing work around the world. Major General Harrington has more than 30 years of experience as a volunteer with civic, public, and non-government organizations. He holds a Bachelor of Science degree in Architectural Engineering; an MBA, and a Master of Science degree in Strategic Studies. As a member of the Rithem Life Sciences team, he brings an impressive level of management expertise and business development knowledge to the group, particularly in U.S. government contracting and strategic management.

Dov Maisel is the Senior Vice President of International Operations for United Hatzalah/Untied Rescue volunteer Emergency Response organizations. He is an active combat medic and a Company Commander in the Israel Defense Forces (Res.), and specializes in a mass disaster, rescue and recovery training for civilians and the military. Maisel is an innovator and inventor of medical technologies and devices implemented in Israel and globally and resides on the International Editorial Board of the Journal of Emergency Medical Services Magazine (JEMS). In addition to his many fields of expertise, Maisel leads Israeli rescue missions to disaster-struck countries such as Haiti and Nepal and has been spearheading international expansion by helping cities all over the world develop community-based emergency response programs based on the model of United Hatzalah.

A.J. Heightman, MPA, EMT-P, is the Editor-Emeritus of the Journal of Emergency Medical Services (JEMS), based out of San Diego, CA. He is also an Adjunct Instructor of Clinical Research and Leadership for the George Washington University School of Medicine and Health Sciences and a member of the San Diego Fire Rescue Academic Advisory Committee. Heightman served as the JEMS Editor-in-Chief for 25 years prior to being honored with Editor Emeritus status. Prior to joining the staff of JEMS, he served for 17 years as Executive Director of the six-county Eastern PA EMS region in Allentown, PA and then as Director of Operations for Cetronia Ambulance in Lehigh County. Throughout his career in Eastern PA, Heightman also served as a paramedic and EMS command officer with the Bethlehem Township Volunteer Fire Dept, and he also served as a part-time paramedic for both the cities of Allentown and Bethlehem EMS divisions. A certified EMS and rescue instructor, He has also served on the faculty of university EMS degree programs; community college emergency service training divisions and fire academies in Pennsylvania. Heightman is widely recognized for his work in the area of EMS management and Mass Casualty Incident (MCI) management. He is a graduate of Temple University and received his master’s degree in Public Administration from Lehigh University.

“Our Strategic Advisory Board is comprised of experienced thought leaders who have a proven track record of success in their respective fields. Their collective skillsets and will help us expedite the manufacturing and strategic distribution of our emerging life-saving products to consumers here in the U.S. and abroad,” explains Jonathan Rosenblum, DPM, CEO of Rithem Life Sciences.

Rithem Life Sciences Announces Medical Advisory Board

03/02/2021

Wilmington DE – Rithem Life Sciences, a Wilmington, Delaware-based medical device company and developer of safe and efficacious life-saving portable products, has announced the formation of its Medical Advisory Board.

The Medical Advisory Board will collaborate with Rithem's leadership team as the company continues advancing the development of its portable, hands-only CPR aid – ResQR and the automated external defibrillator – JoltzAED. The ResQR is ergonomically designed with advanced features such as a placement indicator as well as metronome and LED light guidance to ensure proper positioning of the hands during chest compressions. This allows for the equal spreading of force across the wider surface area of the sternum to reduce the risk of fractures. It is also equipped with a compression pacing system and built-in modesty and personal protection equipment to avoid unnecessarily exposing the recipient's chest while also reducing the risk of potential exposure to and transmission of viruses such as COVID-19.

The Medical Advisory Board is comprised of the following members:

Yehuda Roseman serves as a director and has over 25 years in international business. After a personal incident involving the tragic and sudden loss of his friend’s young son, he was inspired to form Rithem Life Sciences and develop affordable, life-saving, portable products designed to assist anyone in responding to a sudden cardiac arrest event.

Carl Schmigelski, M.D., is a board-certified anesthesiologist and an active member of the Department of Anesthesiology at Winthrop University Hospital and Nassau Anesthesia Associates in Mineola, NY. In 2011, he was appointed director of Non-Operating Room Anesthesia at Winthrop University Hospital and serves as director of Anesthesia for the Winthrop Pediatric Associates, Pediatric Hematology Oncology. In additional to his clinical work, Dr. Schmigelski is an Adjunct Assistant Professor in the Department of Anesthesiology at NYU Long Island School of Medicine.

Paul D. Natterson, M.D., F.A.C.C., is a partner at Pacific Heart Institute (PHI) in Santa Monica, CA where he has served as president and medical director. He began his career as a clinical cardiac electrophysiologist at PNI before transitioning to consultative cardiology in 2010. Since then, he has served in several leadership roles including Chief of Staff and Chief Medical Officer of Providence Saint John's Health Center in Santa Monica. After serving two terms on the hospital's Board of Directors, Dr. Natterson served as a special advisor to the Board and Chair of the Board's Nominating Committee. Dr. Natterson has also served on the Providence Saint John's Health Center Foundation Board's Executive Committee and as the Co-Chair of the Foundation's Board Affairs Committee. He was also a founding member of the Board of Directors of the Saint John's Physician Partners Medical Foundation and Chair of its Specialty Committee. Dr. Natterson now serves as Board President of GoodRx Helps.

Todd Zalut, M.D., trained in emergency medicine in Chicago where he was later appointed project medical director for the Emergency Medical Service (EMS) System of Northwest Chicago. Dr. Zalut first emigrated to Israel in 1990 and was the first residency-trained specialist in emergency medicine in the State of Israel. He returned to Chicago in 1991 to become the co-director of the Emergency Department at Michael Reese Hospital, but eventually returned to Jerusalem in 1993 and served as the assistant director of Terem Emergency Medical Clinics, as a staff physician in the Emergency Department at Kaplan Hospital in Rehovot, and was enlisted in the Israeli Air Force's elite helicopter rescue unit. In 2002, Dr. Zalut was appointed assistant director of the Emergency Department of Shaare Zedek. Since 2003, Dr. Zalut has been the director of the Emergency Department where he has led the "fastest and most significant growth in the country over the last 15 years." In addition to his work at the hospital, Dr. Zalut also served as medical director of Medassis, a company dedicated to repatriating patients who fall ill overseas and need to be safely transported home.

Mark Merlin, M.D., is a Professor of Emergency Medicine at Rutgers New Jersey Medical School and Vice-Chairman of Emergency Medicine at Newark Beth Israel Medical Center/RWJBarnabas Health. He has over 35 years of experience in EMS as a volunteer first-aid responder, paramedic and physician. Dr. Merlin is currently the Founder, CEO and Board Chairman of MD1, which is a 50-member nonprofit dedicated to advancing prehospital care. Dr. Merlin has been involved overseeing prehospital physician response since 2002. For MD1, he manages teams participating in event medicine, tactical response, flight medicine (both rotary and fixed wing) and ground field response. Dr. Merlin has created numerous revenue streams and developed relationships between the business and EMS community to develop support for numerous programs. He has developed an EMS grant and community support and public awareness via social media and community engagement.

"When forming the Medical Advisory Board, we made an asserted effort to assemble an exceptional and highly-trained team of physicians whose clinical expertise and leadership will help us advance our emerging life-saving products," explains Jonathan Rosenblum, DPM, CEO of Rithem Life Sciences. "We are confident that these four physicians will provide Rithem the insightful clinical opinions and recommendations necessary to ensure that our products are both safe and efficacious for its users and recipients."

For more information about Rithem Life Sciences, please visit rithemls.com.

About Rithem Life Sciences

Rithem Life Sciences, headquartered in Wilmington, Delaware, was founded on the desire to develop safe and efficacious lifesaving portable products. The company has developed two at-home and portable devices – the hands-only CPR aid ResQR and the automated external defibrillator JoltzAED. Rithem's goal is to turn anyone into a first responder by giving them confidence to perform proper and high–quality resuscitation.

Rithem Life Sciences Announces Formation of Medical Advisory Board

03/02/2021

Wilmington DE, March 2, 2021 – Rithem Life Sciences, a Wilmington, Delaware-based medical device company and developer of safe and efficacious life-saving portable products, has announced the formation of its Medical Advisory Board.

The Medical Advisory Board will collaborate with Rithem’s leadership team as the company continues advancing the development of its portable, hands-only CPR aid – ResQR and the automated external defibrillator – JoltzAED. The ResQR is ergonomically designed with advanced features such as a placement indicator as well as metronome and LED light guidance to ensure proper positioning of the hands during chest compressions. This allows for the equal spreading of force across the wider surface area of the sternum to reduce the risk of fractures. It is also equipped with a compression pacing system and built-in modesty and personal protection equipment to avoid unnecessarily exposing the recipient’s chest while also reducing the risk of potential exposure to and transmission of viruses such as COVID-19.

The Medical Advisory Board is comprised of the following members:

Yehuda Roseman serves as a director and has over 25 years in international business. After a personal incident involving the tragic and sudden loss of his friend’s young son, he was inspired to form Rithem Life Sciences and develop affordable, life-saving, portable products designed to assist anyone in responding to a sudden cardiac arrest event.

Carl Schmigelski, M.D., is a board-certified anesthesiologist and an active member of the Department of Anesthesiology at Winthrop University Hospital and Nassau Anesthesia Associates in Mineola, NY. In 2011, he was appointed director of Non-Operating Room Anesthesia at Winthrop University Hospital and serves as director of Anesthesia for the Winthrop Pediatric Associates, Pediatric Hematology Oncology. In additional to his clinical work, Dr. Schmigelski is an Adjunct Assistant Professor in the Department of Anesthesiology at NYU Long Island School of Medicine.

Paul D. Natterson, M.D., F.A.C.C., is a partner at Pacific Heart Institute (PHI) in Santa Monica, CA where he has served as president and medical director. He began his career as a clinical cardiac electrophysiologist at PNI before transitioning to consultative cardiology in 2010. Since then, he has served in several leadership roles including Chief of Staff and Chief Medical Officer of Providence Saint John’s Health Center in Santa Monica. After serving two terms on the hospital’s Board of Directors, Dr. Natterson served as a special advisor to the Board and Chair of the Board’s Nominating Committee. Dr. Natterson has also served on the Providence Saint John’s Health Center Foundation Board’s Executive Committee and as the Co-Chair of the Foundation’s Board Affairs Committee. He was also a founding member of the Board of Directors of the Saint John’s Physician Partners Medical Foundation and Chair of its Specialty Committee. Dr. Natterson now serves as Board President of GoodRx Helps.

Todd Zalut, M.D., trained in emergency medicine in Chicago where he was later appointed project medical director for the Emergency Medical Service (EMS) System of Northwest Chicago. Dr. Zalut first emigrated to Israel in 1990 and was the first residency-trained specialist in emergency medicine in the State of Israel. He returned to Chicago in 1991 to become the co-director of the Emergency Department at Michael Reese Hospital, but eventually returned to Jerusalem in 1993 and served as the assistant director of Terem Emergency Medical Clinics, as a staff physician in the Emergency Department at Kaplan Hospital in Rehovot, and was enlisted in the Israeli Air Force’s elite helicopter rescue unit. In 2002, Dr. Zalut was appointed assistant director of the Emergency Department of Shaare Zedek. Since 2003, Dr. Zalut has been the director of the Emergency Department where he has led the “fastest and most significant growth in the country over the last 15 years.” In addition to his work at the hospital, Dr. Zalut also served as medical director of Medassis, a company dedicated to repatriating patients who fall ill overseas and need to be safely transported home.

Mark Merlin, M.D., is a Professor of Emergency Medicine at Rutgers New Jersey Medical School and Vice-Chairman of Emergency Medicine at Newark Beth Israel Medical Center/RWJBarnabas Health. He has over 35 years of experience in EMS as a volunteer first-aid responder, paramedic and physician.

Dr. Merlin is currently the Founder, CEO and Board Chairman of MD1, which is a 50-member nonprofit dedicated to advancing prehospital care. Dr. Merlin has been involved overseeing prehospital physician response since 2002. For MD1, he manages teams participating in event medicine, tactical response, flight medicine (both rotary and fixed wing) and ground field response. Dr. Merlin has created numerous revenue streams and developed relationships between the business and EMS community to develop support for numerous programs. He has developed an EMS grant and community support and public awareness via social media and community engagement.

“When forming the Medical Advisory Board, we made an asserted effort to assemble an exceptional and highly-trained team of physicians whose clinical expertise and leadership will help us advance our emerging life-saving products,” explains Jonathan Rosenblum, DPM, CEO of Rithem Life Sciences. “We are confident that these four physicians will provide Rithem the insightful clinical opinions and recommendations necessary to ensure that our products are both safe and efficacious for its users and recipients.”

Rithem Life Sciences Announces Formation of Board of Directors

02/02/2021

Wilmington DE, February 2, 2021 – Rithem Life Sciences, a Wilmington, Delaware-based medical device company and developer of safe and efficacious life-saving portable products, has announced the formation of its Board of Directors.

The Board of Directors is led by Executive Chairman Philip Werthman, MD, MMH, FACS. Dr. Werthman is a surgeon, military historian, venture capitalist, inventor and entrepreneur. He is the founder and president of Merkava Holdings, the investment, distribution and advisory arm of his venture capital business. Currently, Dr. Werthman also serves as the executive chairman of Proxamama and chairman of the science advisory board of GT Biopharma, Inc. (OTCQB: GTBP) (GTBP.PA). He has resided on advisory boards of 14 private companies in the life sciences and aerospace/defense industries.

Rithem Life Sciences Cofounder and CEO Jonathan Rosenblum, DPM, serves as a director and is a podiatric surgeon and scientist currently practicing his subspecialty in diabetic limb salvage in Jerusalem. Dr. Rosenblum is widely recognized for his research and advancements in podiatry, becoming a sought-after lecturer and author. In 2001, Dr. Rosenblum formed strategic affiliations to advance the future of medicine through new medical devices and startups, culminating in his collaboration with company Cofounder and President Yehuda Roseman and the establishment of Rithem Life Sciences.

Yehuda Roseman serves as a director and has over 25 years in international business. After a personal incident involving the tragic and sudden loss of his friend’s young son, he was inspired to form Rithem Life Sciences and develop affordable, life-saving, portable products designed to assist anyone in responding to a sudden cardiac arrest event.

James W. Keyes serves as a director and is the chairman of Key Development, LLC, an investment group with holdings in real estate and aerospace. He also currently serves as a director for Murphy USE (NYSE: MUSA). Keyes was the former CEO to two Fortune 500 companies – Blockbuster Inc. (NYSE: BBI) and 7-Eleven, Inc. (NYSE: SEI), and he has resided on numerous philanthropic boards, including the national board of governors of the American Red Cross, the Cooper Institute, and Columbia Graduate School of Business.

Mark Genender serves as a director and is a private and growth equity investor and the managing partner of Bristol Growth Capital, LLC. Genender currently serves on the boards of Standard Vision, LLC, QCode Media and Gloss Ventures. In addition, he currently serves as an operating advisor to Torch Capital, an early-stage consumer venture capital fund. Genender’s previous private equity career included senior investment roles at Guggenheim Partners, Star Avenue Capital and Fenway Partners. He is also the president of the Western Region of American Friends of Hebrew University and is a member of the U.S. Investment Committee.

“We are proud to have assembled such an accomplished Board of Directors whose success in their respective industries is unrivaled,” explains Dr. Rosenblum. “With our single-minded vision of providing every household in this country and around the world, affordable life-saving devices to treat sudden cardiac arrest, we are committed to making every responder a rescuer.”

Rithem Life Sciences recently announced its joining the American Heart Association Center for Health Technology & Innovation (the Center) Innovators’ Network to introduce its at-home, hands-only CPR aid and automatic external defibrillator devices (AED) – ResQR and JoltzAED.

Rithem Life Sciences Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

10/26/2020

Rithem Life Sciences has joined the American Heart Association Center for Health Technology & Innovation (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.

The Innovators’ Network is a consortium that connects entrepreneurs, providers, researchers and payers. Innovators’ Network members also have access to the Association’s digital guidelines, recommendations, and best-in-class science as they develop digital healthcare technologies. Members collaborate with the Center in different ways, including the building of models for clinical outcome studies, lowering the significant cost of developing those studies independently, helping connect the science to technology, and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.

“The Center aims to advance the development of evidence-based, scalable, digital health solutions, so it’s incredibly encouraging to see Rithem leveraging this network from the American Heart Association with the aim of improving health education and health engagement,” said Patrick Wayte, senior vice president of the American Heart Association Center for Health Technology & Innovation.

“We are excited to join the Innovators’ Network because it provides us a unique national platform to introduce and potentially expand access to our market disruptive technologies,” explains Jonathan Rosenblum, DPM, co-founder and CEO of Rithem Life Sciences.

About Rithem

Rithem, a medical device company, joins the Innovators’ Network bringing with them an at-home, hands-only CPR aid and an automatic external defibrillator device (AED). The devices are designed to be compact, affordable, and easy to use, with features like hand placement indicators, visible compression pacing indicators and PPE.

About Rithem Life Sciences

Rithem Life Sciences, headquartered in Wilmington, Delaware, was founded on the desire to develop safe and efficacious portable lifesaving products. The company has developed two portable at-home devices— the hands-only CPR aid ResQR and the automated external defibrillator JoltzAED. Rithem’s goal is to turn anyone into a first responder by giving them the confidence to perform proper, high–quality resuscitation.

Schedule a Consultation

Lorem ipsum dolor sit amet, consectetur adipisicing elit. Cupiditate dignissimos doloribus ea earum expedita explicabo ipsa magnam molestiae nam numquam officia officiis quam, quod recusandae rerum, soluta sunt velit voluptas!

302-440-1481

© Rithem Life Sciences. All Rights Reserved. Designed & Developed by Studio III